Filipe E. P. Rodrigues

Mr. Filipe E. P. Rodrigues

Centro de Química e Bioquímica and BioISI: Biosystems and Integrative Sciences Institute, Faculdade de Ciências, Universidade de Lisboa, 1749-016 Lisboa, Portugal
orcid

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 November 2021 in ACS Synthetic Biology
Verified
Journal Article
Closed access
NFNícia Ferreira
Nícia Ferreira
SBSalete J. Baptista
Salete J. Baptista
CBCarlos Barreto
Carlos Barreto
FRFilipe E. P. Rodrigues
Filipe E. P. Rodrigues
TSTomás Silva
Tomás Silva
Irina MoreiraIrina Moreira
Irina Moreira

Verified
Journal Article
Open access
PDF file
FRFilipe E. P. Rodrigues
Filipe E. P. Rodrigues
AFAntónio Figueira
António Figueira
Cláudio M. GomesCláudio M. Gomes
Cláudio M. Gomes
Miguel MachuqueiroMiguel Machuqueiro
Miguel Machuqueiro
S100B is an astrocytic extracellular Ca2+-binding protein implicated in Alzheimer’s disease, whose role as a holdase-type chaperone delaying Aβ42 aggregation and toxicity was recently uncovered. Here, we employ computational biology approaches to dissect the structural details and dynamics of the interaction between S100B and Aβ42. Driven by previous structural data, we used the Aβ25–35 segment, which recapitulates key aspects of S100B activity, as a starting guide for the analysis. We used Haddock to establish a preferred binding mode, which was studied with the full length Aβ using long (1 μs) molecular dynamics (MD) simulations to investigate the structural dynamics and obtain representative interaction complexes. From the analysis, Aβ-Lys28 emerged as a key candidate for stabilizing interactions with the S100B binding cleft, in particular involving a triad composed of Met79, Thr82 and Glu86. Binding constant calculations concluded that coulombic interactions, presumably implicating the Lys28(Aβ)/Glu86(S100B) pair, are very relevant for the holdase-type chaperone activity. To confirm this experimentally, we examined the inhibitory effect of S100B over Aβ aggregation at high ionic strength. In agreement with the computational predictions, we observed that electrostatic perturbation of the Aβ-S100B interaction decreases anti-aggregation activity. Altogether, these findings unveil features relevant in the definition of selectivity of the S100B chaperone, with implications in Alzheimer’s disease.

24 November 2020 in Chemical Communications
Verified
Journal Article
Closed access
PDF file
JCJoana S. Cristóvão
Joana S. Cristóvão
Guilherme MoreiraGuilherme Moreira
Guilherme Moreira
FRFilipe E. P. Rodrigues
Filipe E. P. Rodrigues
ACAna P. Carapeto
Ana P. Carapeto
MRMário S. Rodrigues
Mário S. Rodrigues
Cláudio M. GomesCláudio M. Gomes
Cláudio M. Gomes
A mechanism of chemical regulation of the S100B chaperone via Cu2+ induced assembly of S100B cross-linked oligomers with enhanced anti-amyloid aggregation activity.